Wellington Management Group
OLMA icon

Wellington Management Group’s Olema Pharmaceuticals OLMA Stock Holding History

Wellington Management Group’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.59M Sell
526,446
-138,233
-21% -$1.85M ﹤0.01% 1400
2026
Q1 		$9.91M Buy
664,679
+443,708
+201% +$9.88M ﹤0.01% 1240
2025
Q4 		$5.52M Buy
220,971
+16,764
+8% +$298K ﹤0.01% 1392
2025
Q3 		$2M Sell
204,207
-23,814
-10% -$143K ﹤0.01% 1631
2025
Q2 		$971K Sell
228,021
-1,245,658
-85% -$5.55M ﹤0.01% 1730
2025
Q1 		$5.54M Sell
1,473,679
-51,805
-3% -$261K ﹤0.01% 1351
2024
Q4 		$8.84M Buy
1,525,484
+522,799
+52% +$5.22M ﹤0.01% 1228
2024
Q3 		$12M Buy
1,002,685
+97,428
+11% +$1.25M ﹤0.01% 1116
2024
Q2 		$9.79M Buy
905,257
+69,644
+8% +$755K ﹤0.01% 1156
2024
Q1 		$9.46M Buy
835,613
+736,200
+741% +$9.5M ﹤0.01% 1153
2023
Q4 		$1.39M Buy
99,413
+292
+0.3% +$3.92K ﹤0.01% 1561
2023
Q3 		$1.22M Buy
99,121
+38,011
+62% +$387K ﹤0.01% 1574
2023
Q2 		$552K Buy
+61,110
New +$369K ﹤0.01% 1677
2022
Q3 		– Sell
-275,984
Closed -$1.12M – 2117
2022
Q2 		$1.12M Sell
275,984
-712,055
-72% -$2.26M ﹤0.01% 1658
2022
Q1 		$4.21M Sell
988,039
-1,031,070
-51% -$5.68M ﹤0.01% 1434
2021
Q4 		$18.9M Buy
2,019,109
+369,905
+22% +$7.66M ﹤0.01% 1093
2021
Q3 		$45.5M Buy
1,649,204
+32,906
+2% +$888K 0.01% 841
2021
Q2 		$45.2M Sell
1,616,298
-398,917
-20% -$11.4M 0.01% 854
2021
Q1 		$66.1M Sell
2,015,215
-54,100
-3% -$2.32M 0.01% 730
2020
Q4 		$96.4M Buy
+2,069,315
New +$97M 0.02% 600

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Wellington Management Group's OLMA Position: Q2 2026 in Review

Wellington Management Group reduced its Olema Pharmaceuticals (OLMA) stake by 21% in Q2 2026, selling an estimated $1.85M and leaving 526,446 shares worth $6.59M. The position accounts for ﹤0.01% of the portfolio, ranked #1400.

Wellington Management Group first reported a position in OLMA in Q4 2020 and has held it in 20 quarters since. The position peaked at $96.4M in Q4 2020. 185 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

  • Wellington Management Group held 526,446 shares of Olema Pharmaceuticals worth $6.59M as of Q2 2026.
  • Wellington Management Group sold 138,233 Olema Pharmaceuticals shares in Q2 2026, an estimated $1.85M.
  • Olema Pharmaceuticals made up ﹤0.01% of Wellington Management Group's portfolio in Q2 2026, its #1400 holding.
  • Wellington Management Group first reported a position in Olema Pharmaceuticals in Q4 2020 and has held it in 20 quarters since.
  • Wellington Management Group's Olema Pharmaceuticals position peaked at $96.4M in Q4 2020.
  • 185 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on Wellington Management Group's 13F filing for Q2 2026, filed 14 Aug 2026.